| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 59,736 | 45,732 | 52,097 | 67,214 | | Cost of Revenue | 37,957 | 30,773 | 35,238 | 42,001 | | | Gross Profit | 21,779 | 14,959 | 16,859 | 25,213 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,678 | 21,854 | 22,166 | 27,161 | | Non Recurring |
-
|
-
|
-
| 39 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,899) | (6,895) | (5,307) | (1,987) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (129) | 129 |
-
| | Earnings Before Interest And Taxes | (2,040) | (7,024) | (5,178) | (1,987) | | Interest Expense | (44) | (76) | 120 | (192) | | Income Before Tax | (1,996) | (6,948) | (5,298) | (1,795) | | Income Tax Expense | (650) | (2,284) | (1,664) | (543) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,346) | (4,664) | (3,634) | (1,252) | | | Non-recurring Events | | Discontinued Operations | 5 | 6 |
-
| 23,824 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,341) | (4,658) | (3,634) | 22,572 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,341) | ($4,658) | ($3,634) | $22,572 |
|
0.51% Nasdaq 
0.02 (1.03%) 
Income Statement
